Insecticides (India) Limited has released the transcript of its Earnings Conference Call for the Quarter and Financial Year ended March 31, 2026. The call, which took place on May 28, 2026, discussed the company's performance amidst a challenging global environment, including supply chain constraints and raw material price increases. During the call, management highlighted a steady Q4 performance with approximately 19% growth, driven by both B2C and B2B segments, and premium products showing a 24% growth. For the full year, the company reported over 7% growth with broadly neutral profits. The company's strategy of premiumization and differentiated technologies, with over 25 products launched in the last three years, continues to gain traction. Key initiatives discussed include the strengthening of partnerships with global players like Nissan and Corteva, leading to new product launches such as Altair, SPARCLE, and Granuvia. The strategic growth platform, Kaeros, was also detailed as a means to expand distribution reach and build an independent sales channel. The company's balance sheet remains robust, with planned maintenance capex of ₹25-30 crores for FY27. Looking ahead to FY27, Insecticides (India) Limited expressed cautious optimism, anticipating improved crop activity with the onset of monsoons. The company is entering its 25th year, its Silver Jubilee, and is poised for transformation and growth, focusing on innovation, premiumization, technology, and operational excellence. Financials for FY26 showed revenue from operations at ₹2,140 crores, a 7% increase from FY25, with EBITDA at ₹227 crores. A notable announcement was the addition of Mr. Sanskar Aggarwal, the MD's son, to the Board, accompanied by a proposed ESOP scheme for employees.
